Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

SIK3

RBC: SIK3 · Substrate: AMARA peptide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib97.80.70
Midostaurin96.40.50
Bosutinib94.90.55
Pemigatinib79.40.72
Dabrafenib72.90.63
Neratinib64.60.60
Dacomitinib55.70.66
Fedratinib49.40.58
Repotrectinib41.90.61
Brigatinib37.80.51
Erdafitinib35.70.74
Ripretinib33.60.67
Nintedanib30.70.61
Vandetanib27.50.72
Tenalisib27.40.70

Known variants

No variants catalogued.
Open in new tab